Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity

References

• Azzam E, Toledo S, Gooding T, Little J. 1998. Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiation Research, 150: 497–504.
   PubMed Web of Science ®Google Scholar
• Azzam E, Toledo S, Little J. 2001. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from a-particle irradiated to nonirradiated cells. Proceedings of the National Academy of Sciences. USA 98, 473–478.
   PubMed Web of Science ®Google Scholar
• Ballarinim F, Allonii D, Facoetti A, Mairani A, Nano, R, Ottolenghi A. 2006. Modelling radiation-induced bystander effect and cellular communication. Radiation Protection Dosimetry 122:244–251.
   PubMed Web of Science ®Google Scholar
• Balderson M, Kirkby C. 2014.Potential implications on TCP for external beam prostate cancer treatment when considering the bystander effect in partial exposure scenarios. International Journal of Radiation Biology, 90:133–141.
   Google Scholar
• Belyakov O, Mitchell S, Parlkh D, Randers-Pehrson G, Marino S, Amundson S, Geard C, Brenner D. 2005. Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proceedings of the National Academy of Sciences USA, 102: 14203–14208.
   PubMed Web of Science ®Google Scholar
• Bonner W. 2004. Phenomena leading to cell survival values which deviate from linear-quadratic models. Mutation Research 568:33–39.
   PubMed Web of Science ®Google Scholar
• Brenner D, Little J, Sachs R. 2001.The bystander effect in radiation oncogenesis: Ii. a quantitative model. Radiation Research, 155: 402–408.
   Google Scholar
• Butterworth K, Mcgarry C, Trainor C, McMahon S, Osullivan J, Schettino G, Hounsell A, Prise K. 2012. Dose, dose-rate and field size effects on cell survival following exposure to non-uniform radiation fields. Physics in Medicine and Biology, 57:3197–3206.
   PubMed Web of Science ®Google Scholar
• Ebert M, Suchowerska N, Jackson M, McKenzie D. 2010. A mathematical framework for separating the direct and bystander components of cellular radiation response. Acta Oncologica, 49:1334–1343.
   PubMed Web of Science ®Google Scholar
• Faria F, Dickman R, Moreira C. 2012. Models of the radiation-induced bystander effect. International Journal of Radiation Biology, 88: 592–599.
   PubMed Web of Science ®Google Scholar
• Goitein M. 1985. Causes and consequences of inhomogeneous dose distributions in radiation therapy. International Journal of Radiation Oncology Biology and Physics, 12: 701–704.
   Web of Science ®Google Scholar
• Goldberg Z, Lehnert B. 2012. Radiation-induced effects in unirradiated cells: a review and implications in cancer. International Journal of Oncology, 21:337–349.
   Google Scholar
• Hall E, Giaccia A. 2006. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar
• Hamada N, Matsumoto H, Hara T, Kobayashi Y. 2007. Intercellular and intracellular signalling pathways mediating ionizing radiation- induced bystander effects. Journal of Radiation Research, 48:87–95.
   PubMed Web of Science ®Google Scholar
• Ilnytskyy Y, Koturbash I, Kovalchuk O. 2009. Radiation-induced bystander effects in vivo are epigenetically regulated in a tissue-specific manner. Environmental and Molecular Mutagenesi, 50, 105–13.
   PubMed Web of Science ®Google Scholar
• Kaminski J, Shinohara E, Summers J, Niermann K, Morimoto A, Brousal J. 2005. The controversial abscopal effect. Cancer Treatment Reviews, 31: 159–72.
   PubMed Web of Science ®Google Scholar
• Koturbash I, Loree J, Kutanzi K, Koganow C, Pogribny I, Kovalchuck O. 2008. In vivo bystander effect: cranial X-irradiation leads to elevated DNA damage, altered cellular proliferation and apoptosis, and increased p53 levels in shielded spleen. International Journal of Radiation Oncology Biololgy Physics 70: 554–62.
   PubMed Web of Science ®Google Scholar
• Li M, Alber M, Deasy J, Jackson A, Kenjee K, Marks L, Martel M, Mayo C, Moiseenko V, Nahum A, Niemierko A, Semenenko V, Yorke E. 2012. The use and QA of biologically related models for treatment planning: short report of the tg-166 of the therapy physics committee of the aapm. Medical Physics, 39:1386–1409.
   PubMed Web of Science ®Google Scholar
• Little M, Filipe J, Prise M, Folkard M, Belyakov A. 2005. A model for radiation-induced bystander effects, with allowance for spatial position and the effects of cell turnover. Journal of Theoretical Biology, 232:329–338.
   PubMed Web of Science ®Google Scholar
• Mackonis E, Suchowerska N, Zhang M, Ebert M, McKenzie D.R, Jackson. 2007. Cellular response to modulated radiation fields. Physics in Medicine and Biology. 52: 5469–5482.
   PubMed Web of Science ®Google Scholar
• McMahon S, Butterworth K, McGarry C, Trainor C, Osullivan J, Hounsell A, Prise K. 2012. A computational model of cellular response to modulated radiation fields. International Journal of Radiation Oncology Biology Physics, 84:250–256.
   PubMed Web of Science ®Google Scholar
• McMahon S, Butterwoth K, Trainor C, McGarry C, Osullivan J, Schettino G, Hounsell A, Prise K. 2013a. A kinetic-based model of radiation-induced intercellular signalling. PLoS One, 8:e54526.
   Web of Science ®Google Scholar
• McMahon S, McGarry C, Butterworth K, O’Sullivan J, Hounsell A, Prise K. 2013b. Implications of Intercellular Signaling for Radiation Therapy: A Theoretical Dose-Planning Study. International journal of radiation oncology biology and physics.87:149–1154.
   Web of Science ®Google Scholar
• Morgan W. 2003a. Non-targeted and delayed effects of exposure to ionizing radiation: I. radiation-induced genomic instability and bystander effects in vitro. Radiation Research, 159(5):567–580.
   PubMed Web of Science ®Google Scholar
• Morgan W. 2003b. Non-targeted and delayed effects of exposure to ionizing radiation: Ii. radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiation Research, 159: 581–596.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Colin B. 2002. Radiation-induced bystander effects– implications for cancer. Nat Rev Cancer, 4(2):158–164.
   Web of Science ®Google Scholar
• Munro R, Gilbert C. 1961. The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br J Radiol, 34:246–251.
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Little J. 1992. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res, 52(22):6394–6396.
   PubMed Web of Science ®Google Scholar
• Niemierko A. 1997. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Medical Physics 24: 103–110.
   PubMed Web of Science ®Google Scholar
• Nikjoo H, Khvostunov I. 2003. Biophysical model of the radiation-induced bystander effect. International Journal of Radiation Biology, 79(1):43–52.
   PubMed Web of Science ®Google Scholar
• Partridge M. 2008. A radiation damage repair model for normal tissues. Physics in Medicine and Biology, 53:3595–3608.
   PubMed Web of Science ®Google Scholar
• Pedicini P, Strigari L, Benassi M. 2013. Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. International Journal of Radiation Oncology Biology Physics, 85:235–237.
   Web of Science ®Google Scholar
• Prise K, Osullivan J. 2009. Radiation-induced bystander signalling in cancer therapy. Nature Reviews Cancer, 9:351–360.
   PubMed Web of Science ®Google Scholar
• Shuryak I, Sachs R, Brenner D. 2007. Biophysical models of radiation bystander effects: 1. spatial effects in three-dimensional tissues. Radiation Research, 168:741–749.
   PubMed Web of Science ®Google Scholar
• Sjostedt S, Bezak E. 2010. Non-targeted effects of ionising radiation and radiotherapy. Australasian Physical and Engineering Science in Medicine, 33:219–231.
   PubMed Web of Science ®Google Scholar
• Stewart R, Ratnayake R, Jennings K. 2006. Microdosimetric model for the induction of cell killing through medium-borne signals. Radiation Research, 165:460–469.
   PubMed Web of Science ®Google Scholar
• Strigari L, Orlandini L, Andriani I, Angelo A, Stefanacci M, Nallo A, Benassi M. 2008. A mathamatical approach for evaluation the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatment. Physics in Medicine and Biology, 53: 5045–5059.
   PubMed Web of Science ®Google Scholar
• Wang J, Geurrero M, Li X. 2003.How low is the alpha/beta ratio for prostate cancer? International Journal of Oncology Biology Physics, 55:194–203.
   Google Scholar
• Washida H, Tsugaya M, Hirao N, Sakaqami H, Iwase Y. 1985. Pharmacokinetic study of cefmenoxime concerning its transfer into tissues. The Japanese Journal of Antibiotics, 38: 1648–53.
   PubMedGoogle Scholar
• Webb S, Evans PM, Swindell W, Deasy JO. 1994. A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume. Physics in Medicine and Biology, 39: 2091–2098.
   PubMed Web of Science ®Google Scholar
• Webb S, Nahum A E. 1993. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Physics in Medicine and Biology, 38: 653–666.
   PubMed Web of Science ®Google Scholar
• Yaes R. 1990. The biological effect of inhomogeneous dose distributions in fractionated radiotherapy. International Journal of Radiation Oncology Biology Physics, 19: 203–207.
   PubMed Web of Science ®Google Scholar
• Yorke E. 2001. Modeling the effects of inhomogeneous dose distributions in normal tissues. Seminars in Radiation Oncology, 11: 197–209.
   PubMed Web of Science ®Google Scholar